• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA PLUS VASCULAR COVERED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA PLUS VASCULAR COVERED STENT Back to Search Results
Catalog Number AASLE10080
Device Problem Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/13/2022
Event Type  malfunction  
Event Description
It was reported that during a transjugular intrahepatic portosystemic shunt placement procedure, the stent allegedly had shorter length after deployment.The procedure was completed using another device.There was no reported patient injury.
 
Manufacturer Narrative
The catalog number identified has not been cleared in the us but is similar to the covera plus vascular covered stent system that are cleared in the us.The pro code and 510 k number for the covera plus vascular covered stent system are identified.As the lot number for the device was provided, a review of the device history record is currently being performed.The device has not been returned to the manufacturer for evaluation.However, images were provided for review.The investigation of the reported event is currently underway.(expiry date: 09/2023).
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the covera plus vascular covered stent system that are cleared in the us.The pro code and 510 k number for the covera plus vascular covered stent system are identified in d2 and g4.H10: manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the physical sample is not available for evaluation.Images were provided demonstrating two placed stents with poor resolution; a strut evaluation for stent elongation/ foreshortening was not possible.Adequate scaling information was not provided so that an accurate length measurement was not possible which leads to inconclusive evaluation result.Based on the provided information, the investigation is inconclusive for reported issue.A definite root cause for the reported event could not be determined.The reported indication represents an off-label use of the device.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.The instruction for use state: 'during covered stent release, do not hold the 30 cm long distal catheter assembly segment as it must be free to move and slide into the white stability sheath.', and ' (.) maintain a stationary hold on the white stability sheath during covered stent deployment and adjust for placement accuracy if necessary.Hold the white stability sheath as close as possible to the introducer without touching the dark brown moving catheter of the distal catheter assembly.Maintain the remainder of the white stability sheath (segment between left and right hand on illustration) relaxed and avoid tension.' in regard to anatomy the instruction for use state: 'make sure that the proximal covered stent end is positioned in a straight section of the vessel during deployment'.In regard to pta the instruction for use state: 'pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated.' in regard to choose of the appropriate stent length the instruction for use state: 'ensure the selected covered stent length covers the entire lesion and both ends of the implant extend at least 5 mm into the non-diseased segment of the vessel.' under potential complications and adverse events, the instruction for use state 'inaccurate deployment'.The covera plus vascular covered stent is indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an arterio-venous (av) access graft or fistula and for the treatment of atherosclerotic lesions in iliac and femoral arteries.H10: d4 (expiry date: 09/2023), g3 h11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported that during a transjugular intrahepatic portosystemic shunt placement procedure, the stent allegedly had shorter length after deployment.The procedure was completed using another device.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA PLUS VASCULAR COVERED STENT
Type of Device
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key14586675
MDR Text Key293502684
Report Number9681442-2022-00171
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741136283
UDI-Public(01)00801741136283
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P170042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberAASLE10080
Device Lot NumberANFW2040
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age21 YR
Patient SexFemale
Patient Weight45 KG
-
-